_2020091018165303jzv.jpg "Decoding The World Of ETF")
-
My Account
My Account
As on 01 Mar, 2021 | 01:32
As on --
(OI , PRICE )
As on --
| Open | 2,342.25 |
| Previous Close | 2,300.70 |
| UC Limit | 2,530.75 |
| LC Limit | 2,070.65 |
| Volume | 92,103.00 |
| VWAP | 2,313.70 |
| Mkt Cap (Rs. Cr.) | 19,256 |
| 20D Avg Volume | 265,837 |
| 20D Avg Delivery | 78,293 |
| Beta | 0.510.49 |
| Face Value | 10.00 |
| TTM EPS | 28.88 |
| TTM PE | 80.00 |
| Sector PE | 69.41 |
| Book Value Per Share | 126.48 |
| P/B | 18.27 |
| Dividend Yield | 0.52 |
| P/C | 61.43 |
*Refresh in 20 seconds.
Mid range performer: Stock with medium financial performance with average price momentum and valuation. These stocks may be affordable and are showing some investors interest.
indicates Average Financials
| Revenue | 13.8% |
| NetProfit | 13.5% |
| OperatingProfit | 13.1% |
| R1 | R2 | R3 | PP | S1 | S2 | S3 | |
|---|---|---|---|---|---|---|---|
| Classic | - - | - - | - - | - - | - - | - - | - - |
| Fibonacci | - - | - - | - - | - - | - - | - - | - - |
| Camarilla | - - | - - | - - | - - | - - | - - | - - |
Note : Support and Resistance level for the day, calculated based on price range of the previous trading day.
| R1 | - - | Pivot - - |
S1 | - - |
| R2 | - - | S2 | - - | |
| R3 | - - | S3 | - - |
Note : Support and Resistance level for the day, calculated based on price range of the previous trading day.
| Days | |
|---|---|
| 5 | - - |
| 10 | - - |
| 20 | - - |
| 50 | - - |
| 100 | - - |
| 200 | - - |
| Type | R1 | R2 | R3 | PP | S1 | S2 | S3 |
|---|---|---|---|---|---|---|---|
| Classic | - - | - - | - - | - - | - - | - - | - - |
| Fibonacci | - - | - - | - - | - - | - - | - - | - - |
| Camarilla | - - | - - | - - | - - | - - | - - | - - |
Note : Support and Resistance level for the week, calculated based on price range of the previous trading week.
| R1 | - - | Pivot - - |
S1 | - - |
| R2 | - - | S2 | - - | |
| R3 | - - | S3 | - - |
Note : Support and Resistance level for the week, calculated based on price range of the previous trading week.
| Days |
|---|
| Type | R1 | R2 | R3 | PP | S1 | S2 | S3 |
|---|---|---|---|---|---|---|---|
| Classic | - - | - - | - - | - - | - - | - - | - - |
| Fibonacci | - - | - - | - - | - - | - - | - - | - - |
| Camarilla | - - | - - | - - | - - | - - | - - | - - |
Note : Support and Resistance level for the month, calculated based on price range of the previous trading month.
| R1 | - - | Pivot - - |
S1 | - - |
| R2 | - - | S2 | - - | |
| R3 | - - | S3 | - - |
Note : Support and Resistance level for the month, calculated based on price range of the previous trading month.
| Days |
|---|
| 1 Week | --% | |
| 1 Month | --% | |
| 3 Months | --% | |
| YTD | --% | |
| 1 Year | --% | |
| 3 Years | --% |
Aarti Industries, Dr Lal Path Labs, HDFC AMC to be included in NSE F&O from January Dec 18 2020 08:12 AM
How Odisha government's Rs 400 price cap on RT-PCR tests may push others to follow suit Dec 06 2020 01:12 PM
Dr Lal PathLabs' Q2 net profit rises 6%, revenue up 18% YoY Nov 06 2020 03:11 PM
Dr Lal PathLabs exposed data of millions of patients, including COVID-19 test results: Report Oct 09 2020 08:10 PM
ye kab bhagega, why this stock moving so slow when the entire market is bullish? View more
Posted by : HarshShah09
Guys its lal paths time now huge bull run expected tomorrow very soon it will cross 2500 levels View more
Posted by : Aqua123
Buy Lal path lab @2310 for short term target of 2425, very soon. View more
Posted by : AK5913
| Qty 127666 | Price 1032.65 | % Traded 0.15 |
| Qty 127666 | Price 1032.65 | % Traded 0.15 |
*Transaction of a minimum quantity of 500,000 shares or a minimum value of Rs 5 crore.
| Qty 422494 | Price 840 | % Traded 0.51 |
| Qty 1200000 | Price 780.72 | % Traded 1.44 |
| Qty 900000 | Price 780.26 | % Traded 1.08 |
| Qty 550100 | Price 950.02 | % Traded 0.66 |
| Qty 1291920 | Price 950.27 | % Traded 1.55 |
| Qty 1225260 | Price 1000.38 | % Traded 1.47 |
| Qty 447966 | Price 877.66 | % Traded 0.54 |
| Qty 447966 | Price 877.99 | % Traded 0.54 |
*A bulk deal is a trade where total quantity of shares bought or sold is more than 0.5% of the equity shares of a company listed on the exchange.
| Qty 3365 | Price 10 | % Traded 0.00 | Post Tnx Hold. 0.88% |
| Qty 1500 | Price 10 | % Traded 0.00 | Post Tnx Hold. 0.02% |
| Qty 600 | Price 10 | % Traded 0.00 | Post Tnx Hold. 0.01% |
| Qty 1050 | Price 10 | % Traded 0.00 | Post Tnx Hold. 0% |
| Qty 400 | Price 10 | % Traded 0.00 | Post Tnx Hold. 0.02% |
| Qty 500 | Price 2423.9 | % Traded 0.00 | Post Tnx Hold. 0.02% |
*Disclosures under SEBI Prohibition of Insider Trading Regulations, 2015
| Qty 46912 | Price 0 | % Traded 0.05 | Post Tnx Hold. 4.37% |
| Qty 45487 | Price 0 | % Traded 0.05 | Post Tnx Hold. 5.04% |
| Qty 45487 | Price 0 | % Traded 0.05 | Post Tnx Hold. 5.04% |
| Qty 1681774 | Price 0 | % Traded 2.02 | Post Tnx Hold. 56.91% |
| Qty 1681774 | Price 0 | % Traded 2.02 | Post Tnx Hold. 56.91% |
| Qty 1681774 | Price 0 | % Traded 2.02 | Post Tnx Hold. 56.91% |
*Disclosures under SEBI SAST (Substantial Acquisition of Shares and Takeovers) Regulations, 2011
| Date | Agenda |
|---|
| Ex-Date | Type | Dividend (%) |
|---|
| Announcement Date | Ex-Bonus | Ratio |
|---|
| Ex-Split | Old FV | New FV |
|---|
| Ex-Right | Ratio | Premium |
|---|
| Date | Agenda |
|---|
| Company Name | Price | % Chg | MCap | TTM PE | P/B | ROE | 1 Yr Perform | Net Profit | Net Sales | Debt to Equity |
|---|---|---|---|---|---|---|---|---|---|---|
| Dr Lal PathLab | 2328.75 | 1.22 | 19408.94 | 80.64 | 18.41 | 21.86 | 43.03 | 227 | 1,330 | 0.00 |
| Apollo Hospital | 3067.55 | 0.29 | 42677.34 | 211.41 | 12.31 | 13.62 | 76.72 | 434 | 11,246 | 1.00 |
| Max Healthcare | 185.55 | 2.34 | 16783.60 | - | 10.40 | 2.23 | - | 26 | 1,134 | 0.65 |
| Fortis Health | 168.75 | 6.57 | 12739.92 | - | 1.77 | 0.86 | 9.54 | 79 | 4,632 | 0.20 |
| Metropolis | 1962.50 | 0.16 | 10031.67 | 73.09 | 19.17 | 24.32 | 6.05 | 128 | 856 | 0.00 |
Your feedback matters! Tell us what we got right and what we didn’t? Click here>
